Anheuser Busch Inbev NV ADR (BUD) — chart, structure and Closelook read

Pick a ticker to load its detail page.

Signals for this name

Every Closelook reading that exists for BUD, from the same nightly bakes the boards use. Research diary readings, not advice.

Peer group

Consumer Defensive · US

Scored names in the same sector and country from the Closelook universe.

Compared against BUD on the nightly bakes; the Peers tab ranks the cohort on the Closelook scores where it exists.

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

About Anheuser Busch Inbev NV ADR

Anheuser Busch Inbev NV ADR (BUD) trades on US exchanges, classified under Consumer Defensive.

The Closelook company score reads 51/100 composite (momentum 57, quality 52, valuation 66) across 7 modules — the full three-layer breakdown, chart structure and analog history load live above.

closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

FAQ · from the current data · as of 2026-09-15

Quick answers

What is Anheuser Busch Inbev NV ADR (BUD)?

Anheuser Busch Inbev NV ADR trades as BUD on the US exchange (US) and is classified under Consumer Defensive in the Closelook research universe, as of the registry build of 2026-09-15.

Is BUD in a Closelook index?

Not currently — Anheuser Busch Inbev NV ADR is tracked in the Closelook research universe but is not a constituent of a Closelook functional index as of 2026-09-15.

What is Anheuser Busch Inbev NV ADR's Closelook composite score?

51 out of 100, with momentum 57, quality 52 and valuation 66 sub-scores, as of 2026-09-15. Scores are Closelook's own research readings, not ratings or investment advice.

What does this page show?

A live price chart with SMA overlays and drawing tools for BUD, performance metrics, index-membership context and the Closelook structure read — an investment research diary view, not investment advice.

Related in the Closelook universe